Cardinal Health (NYSE: CAH), a leading pharmaceuticals distributor, on Tuesday reported an increase in adjusted profit for the fourth quarter of 2025. Revenues remained broadly unchanged.
Revenue was nearly flat at $60.2 billion in Q4; excluding special items, the top-line increased 21% Fourth quarter operating earnings were $428 million; adjusted operating earnings increased 19% to $719 millionOn a reported basis, the company posted earnings of $1.00 per share for Q4, which is up 4% year-over-yearFourth-quarter adjusted earnings per share increased 13% annually to $2.08The management raised its fiscal year 2026 outlook for adjusted earnings per share to $9.30 to $9.50, representing a 12-15% growthFull-year revenue is expected to grow in the range of 11% to 13%Global Medical Products and Distribution segment revenue is expected to grow between 2% and 4%
